Gliclada

Medicinal product

(Invented) name

Gliclada

Active substance (s)

Gliklazidas

Strength

30 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BB09, Gliclazide

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2024-12-23

Date of renewal

Documents

2294_Gliclada 30mg_modif_atpal_tab_PL_2024-12-23.docx

2294_Gliclada 30mg_modif_atpal_tab_PZ_2024-12-23.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Gliklazidas	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116047	102148	1102148	lizdinė plokštelė	N60		Receptinis	LT/L/24/2294/001	Tiekiama	2025-06-16	-	No	-	-	Download

Stadijos

Data	Stadija
2024-12-23	Registruotas